Skip to content
10-Q

Quarterly Report

ONCOSEC MEDICAL INCORPORATED

0001493152-22-035598

← back to feed
Filed
Dec 15, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · Dec 15, 2022 2.97M sh
Cash And Equivalents Q1 2023 · Dec 2, 2022 $8.1M
Cash And Equivalents Q1 2023 · Oct 31, 2022 $5.73M
Cash And Equivalents Q1 2023 · Jul 31, 2022 $12.3M
Operating Cash Flow Q1 2023 · Oct 31, 2022 −$6.13M
Operating Cash Flow Q1 2023 · Oct 31, 2021 −$9.87M
Stockholders Equity Q1 2023 · Oct 31, 2022 −$984.45K
Stockholders Equity Q1 2023 · Jul 31, 2022 $6.12M
Stockholders Equity Q1 2023 · Oct 31, 2021 $28.78M
Stockholders Equity Q1 2023 · Jul 31, 2021 $38.08M
Current Liabilities Q1 2023 · Oct 31, 2022 $6.91M
Current Liabilities Q1 2023 · Jul 31, 2022 $6.63M
Total Liabilities Q1 2023 · Oct 31, 2022 $15.42M
Total Liabilities Q1 2023 · Jul 31, 2022 $15.76M
Current Assets Q1 2023 · Oct 31, 2022 $8.63M
Current Assets Q1 2023 · Jul 31, 2022 $15.23M
Total Assets Q1 2023 · Oct 31, 2022 $14.44M
Total Assets Q1 2023 · Jul 31, 2022 $21.88M
Eps Basic Q1 2023 · Oct 31, 2022 −$4.50
Eps Basic Q1 2023 · Oct 31, 2021 −$5.51
Rd Expense Q1 2023 · Oct 31, 2022 $4.77M
Rd Expense Q1 2023 · Oct 31, 2021 $6.65M
Net Income Q1 2023 · Oct 31, 2022 −$8.06M
Net Income Q1 2023 · Oct 31, 2021 −$9.81M
Operating Income Q1 2023 · Oct 31, 2022 −$7.31M
Operating Income Q1 2023 · Oct 31, 2021 −$9.92M